Literature DB >> 8645285

Mitochondrial DNA 3394 mutation in the NADH dehydrogenase subunit 1 associated with non-insulin-dependent diabetes mellitus.

M Hirai1, S Suzuki, M Onoda, Y Hinokio, L Ai, A Hirai, M Ohtomo, K Komatsu, S Kasuga, Y Satoh, H Akai, T Toyota.   

Abstract

Mitochondrial DNA (mtDNA) mutation is associated with a subtype of non-insulin-dependent diabetes mellitus (NIDDM). We identified two homoplasmic mtDNA mutations at the positions of 3394 (T-C) and 3423 (G-T) in a NIDDM patient with clinical features of mitochondrial encephalopathy. The mtDNA 3394T-C mutation changed a conserved tyrosine to a histidine in NADH dehydrogenase subunit 1. The frequency of mtDNA 3994 T-C mutation was determined with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) in general NIDDM patients and nondiabetic control subjects. The mutation was seen in 4.9% of NIDDM patients and 1.3% of nondiabetic controls. It is indicated that the mtDNA 3394 T-C mutation is associated with NIDDM in Japan.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645285     DOI: 10.1006/bbrc.1996.0324

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Mitochondrial diabetes mellitus.

Authors:  J A Maassen; G M C Janssen; H H J P Lemkes
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

2.  Compressive Optic Neuropathy with a Concurrent Mutation of Leber's Hereditary Optic Neuropathy: A Case Report.

Authors:  Yooyeon Park; Kyong Ohn; Ye Jin Ahn; Jinhee Jang; Shin Hae Park
Journal:  Neuroophthalmology       Date:  2020-01-28

3.  Clinical and molecular features of two diabetes families carrying mitochondrial ND1 T3394C mutation.

Authors:  Xiaohong You; Xueming Huang; Luowen Bi; Rui Li; Lin Zheng; Changzheng Xin
Journal:  Ir J Med Sci       Date:  2021-04-11       Impact factor: 1.568

Review 4.  Mitochondrial diseases caused by mtDNA mutations: a mini-review.

Authors:  Anastasia I Ryzhkova; Margarita A Sazonova; Vasily V Sinyov; Elena V Galitsyna; Mariya M Chicheva; Alexandra A Melnichenko; Andrey V Grechko; Anton Yu Postnov; Alexander N Orekhov; Tatiana P Shkurat
Journal:  Ther Clin Risk Manag       Date:  2018-10-09       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.